Judy Li

Judy Li, Ph.D., is a global pharmaceutical executive with a distinguished career in biostatistics and regulatory affairs. They have held leadership roles at prestigious organizations, including AstraZeneca, where they currently serve as Executive Director, overseeing late oncology statistics and hematology strategy. Judy has a robust background in statistical consulting, having previously worked at the FDA and leading biostatistics at Bristol Myers Squibb and Celgene. They are also actively involved as the Chair-elect for the ASA BIOP and continue their education at the University of California, Riverside, pursuing a Ph.D. in Statistics.